Clinical Scorecard: Turning Routine Slides Into Molecular Maps

At a Glance

Key Highlights

• AI tools can provide molecular insights faster and at lower costs compared to traditional sequencing.
• Path2Omics predicts bulk molecular information from pathology images across 30 tumor types.
• Path2Space aims to infer spatial transcriptomics from digital pathology images.
• AI-derived spatial characterization outperformed multi-omics approaches in predicting treatment response.

Guideline-Based Recommendations

Diagnosis

• Utilize AI platforms to infer molecular data from routine pathology slides.

Management

• Incorporate inferred bulk and spatial molecular insights into treatment decision-making.

Monitoring & Follow-up

• Evaluate the predictive performance of AI models against traditional methods.

Risks

• Consider the potential for information overload with detailed spatial data.

Patient & Prescribing Data

Patients undergoing cancer treatment.

AI models can help match patients to therapies based on inferred molecular data.

Clinical Best Practices

• Leverage AI tools to enhance the accessibility of molecular insights in clinical settings.
• Focus on validating AI models before clinical application.

Related Resources & Content